RE:RE:RE:Yep - bad move by MarathonGiven the uncertainty in today's environment it was a smart move to raise more funding. Plus, they waited until the stock price had come back to about where it was before the pandemic.
First, with 15m more new shares, actual dilution is around 3%. Second, it's only a 1/2 warrant, exercisable within a year, at $1.90.
The unfortunate reality with juniors is that when they raise new equity it is usually at a discount to market price and frequently carries warrants.
I don't love the deal, but am comfortable with it.